| __timestamp | Celldex Therapeutics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 1271353000 |
| Thursday, January 1, 2015 | 100171000 | 1620577000 |
| Friday, January 1, 2016 | 102726000 | 2052295000 |
| Sunday, January 1, 2017 | 96171000 | 2075142000 |
| Monday, January 1, 2018 | 66449000 | 2186100000 |
| Tuesday, January 1, 2019 | 42672000 | 3036600000 |
| Wednesday, January 1, 2020 | 42534000 | 2735000000 |
| Friday, January 1, 2021 | 53311000 | 2908100000 |
| Saturday, January 1, 2022 | 82258000 | 3592500000 |
| Sunday, January 1, 2023 | 118011000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
In pursuit of knowledge
In the competitive world of biotechnology, investment in research and development (R&D) is a key driver of innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Regeneron consistently outpaced Celldex, investing nearly 30 times more in R&D by 2023. This significant investment has allowed Regeneron to maintain a leading edge in the industry, with a steady increase in R&D spending, peaking at $4.4 billion in 2023. In contrast, Celldex's R&D expenses fluctuated, with a notable dip in 2019, before rebounding to $118 million in 2023. This disparity highlights the strategic differences between the two companies, with Regeneron focusing on aggressive innovation and Celldex adopting a more conservative approach. As the biotech landscape evolves, these investment strategies will continue to shape their competitive positions.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and Celldex Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Celldex Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dynavax Technologies Corporation and Celldex Therapeutics, Inc.